Gregory Gene Freitag
CIK 1492710 · General Counsel · last filed 2026-03-03
Gregory Gene Freitag is a General Counsel who has filed 68 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for PDSB, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$4.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.71M
4
68
-$4.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PDSB | Director | 61,213 | $0.69 | $42.3K | $75.0K | 10 | 2026-03-03 |
| ZyVersa Therapeutics, Inc. (ZVSA) Delisted | Director | — | $0.20 | — | $0 | 2 | 2025-07-15 |
| AXGN | Director | 283,498 | $41.15 | $11.67M | -$4.12M | 43 | 2024-06-06 |
| PRESSURE BIOSCIENCES INC (PBIO) Delisted | Director | 1,422 | — | — | $0 | 3 | 2011-10-07 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2025-07-15 | ZyVersa Therapeutics, Inc. (ZVSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2025-03-03 | PDSB | Buy (P) | +15,060 | $25.0K | EDGAR |
| 2024-08-13 | AXGN | Notice (144) | −15,000 | -$167.5K | EDGAR |
| 2024-07-18 | ZyVersa Therapeutics, Inc. (ZVSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | AXGN | Exer (M) | +11,904 | $0 | EDGAR |
| 2024-03-08 | AXGN | Sell (S) | −25,000 | -$225.0K | EDGAR |
| 2024-03-07 | AXGN | Notice (144) | −25,000 | -$225.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.